Salim S. Abdool Karim

Immunological correlates of the HIV-1 replication-competent reservoir size.

Ismail SD, Riou C, Joseph SB, Archin NM, Margolis DM, Perelson AS, Cassidy T, Abrahams MR, Moeser M, Council OD, McKinnon LR, Osman F, Abdool Karim Q, Abdool Karim SS, Swanstrom R, Williamson C, Garrett NJ, Burgers WA.

Clin Infect Dis. 2021 Jun 28. PMID: 34181706

Transient association between semen exposure and biomarkers of genital inflammation in South African women at risk of HIV infection.

Jewanraj J, Ngcapu S, Osman F, Ramsuran V, Fish M, Mtshali A, Singh R, Mansoor LE, Abdool Karim SS, Abdool Karim Q, Passmore JS, Liebenberg LJP.

J Int AIDS Soc. 2021 Jun. 24(6):e25766. PMID: 34164927

Epigenetic Regulation of BST-2 Expression Levels and the Effect on HIV-1 Pathogenesis.

Singh R, Ramsuran V, Naranbhai V, Yende-Zuma N, Garrett N, Mlisana K, Dong KL, Walker BD, Abdool Karim SS, Carrington M, Ndung'u T.

Front Immunol. 2021. 12:669241. PMID: 34025670

Plasma Biomarkers of Risk of Tuberculosis Recurrence in HIV Co-Infected Patients From South Africa.

Pillay K, Lewis L, Rambaran S, Yende-Zuma N, Archary D, Gengiah S, Govender D, Hassan-Moosa R, Samsunder N, Abdool Karim SS, McKinnon LR, Padayatchi N, Naidoo K, Sivro A.

Front Immunol. 2021. 12:631094. PMID: 33841412

New SARS-CoV-2 Variants - Clinical, Public Health, and Vaccine Implications.

Abdool Karim SS, de Oliveira T.

N Engl J Med. 2021 05 13. 384(19):1866-1868. PMID: 33761203

Appropriate names for COVID-19 variants.

Abdool Karim SS, de Oliveira T, Loots G.

Science. 2021 03 19. 371(6535):1215. PMID: 33737481

Impact of point-of-care testing and treatment of sexually transmitted infections and bacterial vaginosis on genital tract inflammatory cytokines in a cohort of young South African women.

Garrett N, Mtshali A, Osman F, Masson L, McKinnon LR, Singh R, Mitchev N, Ngobese H, Kharsany ABM, Abdool Karim S, Mlisana K, Passmore JA, Rompalo A, Mindel A, Liebenberg L.

Sex Transm Infect. 2021 Feb 19. PMID: 33608480

Clinical Trials of Broadly Neutralizing Monoclonal Antibodies for Human Immunodeficiency Virus Prevention: A Review.

Mahomed S, Garrett N, Baxter C, Abdool Karim Q, Abdool Karim SS.

J Infect Dis. 2021 Feb 13. 223(3):370-380. PMID: 32604408

Assessing the safety and pharmacokinetics of the anti-HIV monoclonal antibody CAP256V2LS alone and in combination with VRC07-523LS and PGT121 in South African women: study protocol for the first-in-human CAPRISA 012B phase I clinical trial.

Mahomed S, Garrett N, Karim QA, Zuma NY, Capparelli E, Baxter C, Gengiah T, Archary D, Samsunder N, Rose ND, Moore P, Williamson C, Barouch DH, Fast PE, Pozzetto B, Hankins C, Carlton K, Ledgerwood J, Morris L, Mascola J, Abdool Karim S.

BMJ Open. 2020 11 26. 10(11):e042247. PMID: 33243815

Antibody Isotype Switching as a Mechanism to Counter HIV Neutralization Escape.

Scheepers C, Bekker V, Anthony C, Richardson SI, Oosthuysen B, Moyo T, Kgagudi P, Kitchin D, Nonyane M, York T, Mielke D, Mabvakure BM, Sheng Z, Lambson BE, Ismail A, Garrett NJ, Abdool Karim SS, Shapiro L, Williamson C, Morris L, Moore PL.

Cell Rep. 2020 11 24. 33(8):108430. PMID: 33238131